A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Clinical trial NCT01217073 · COMPLETED

Trial details

NCT number: NCT01217073
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-10-08
Primary completion: 2012-01-03
Enrollment: 685

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.